Tecsys Inc
TSX:TCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tecsys Inc
TSX:TCS
|
CA |
|
U
|
UniVision Engineering Ltd
LSE:UVEL
|
HK |
|
W
|
Western Superconducting Technologies Co Ltd
SSE:688122
|
CN |
Tecsys Inc
TECSYS, Inc. engages in the development and marketing of enterprise wide distribution software and related services. The company is headquartered in Montreal, Quebec and currently employs 655 full-time employees. The firm also provides related consulting, education, and support services. The Company’s supply chain solutions include Elite enterprise, Elite healthcare, Omni retail, and Streamline. The company also offers business consulting services, including warehousing and inventory management, transportation and logistics, procurement planning, business intelligence, accounting and finance, and business process re-engineering. The firm offers a range of services, including support services, system enhancement, cloud services, advisory services, software as a service subscriptions, maintenance and support services, professional services (including implementation, consulting and training services provided to customers as well as reimbursable expenses), licenses and hardware.
TECSYS, Inc. engages in the development and marketing of enterprise wide distribution software and related services. The company is headquartered in Montreal, Quebec and currently employs 655 full-time employees. The firm also provides related consulting, education, and support services. The Company’s supply chain solutions include Elite enterprise, Elite healthcare, Omni retail, and Streamline. The company also offers business consulting services, including warehousing and inventory management, transportation and logistics, procurement planning, business intelligence, accounting and finance, and business process re-engineering. The firm offers a range of services, including support services, system enhancement, cloud services, advisory services, software as a service subscriptions, maintenance and support services, professional services (including implementation, consulting and training services provided to customers as well as reimbursable expenses), licenses and hardware.
Record EBITDA: Adjusted EBITDA reached $5.0 million in Q3, up 43% year-over-year — the highest adjusted EBITDA quarter in company history.
SaaS momentum: SaaS revenue was $20.1 million (up 17% YoY) and SaaS ARR ended at $83.3 million (up 10% YoY; 16% constant currency) with record Q3 SaaS bookings led by new logos.
Pipeline strength: Ending Q3 pipeline was up 30% year-over-year and new-logo bookings over the past 12 months are up more than 150%. Pharmacy pipeline grew >200% YoY.
Product news: TecsysIQ (AI intelligence layer) became commercially available in Q3; management expects it to add ARR and drive incremental platform demand over time.
Profitability & margins: Gross margin improved to 51% (from 47% a year ago); YTD adjusted EBITDA rose to $13.3 million from $9.1 million.
Cost actions: Announced ~7% workforce reduction with a Q4 restructuring charge of $4.5 million, expected to generate about $8.1 million in annual operating cost savings.
Guidance reaffirmed: Full-year guidance reaffirmed for SaaS revenue growth of 20–22%, total revenue growth of 8–10%, and adjusted EBITDA margin of 8–9%.
Balance sheet & capital return: Cash and short-term investments of $36.2 million, no debt; $3.7 million used in Q3 for NCIB buybacks; Board approved quarterly dividend of $0.09 per share.
